Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25781533 | 0.87 | TK1 (0.58) | TK1MEN1TSHRKMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL31087990 | 0.85 | MEN1 (0.48) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL22571148 | 0.82 | MEN1 (0.52) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL3457921 | 0.81 | MEN1 (0.50) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL10001689 | 0.79 | KDM4E (0.48) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL23487511 | 0.78 | MEN1 (0.46) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL22399456 | 0.78 | MEN1 (0.44) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL27056634 | 0.78 | MEN1 (0.48) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL27056630 | 0.78 | MEN1 (0.48) | TK1MEN1TSHRKMT2AKDM4E | |
| SCHEMBL22765060 | 0.77 | KDM4E (0.48) | TK1MEN1TSHRKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109451740-B | Cyclic dinucleotides for the treatment of disorders associated with STING activity, such as cancer | 先天肿瘤免疫公司 | 2022-09-02 | — | — | CN | disclosed |